Akanda Corp. (AKAN)
NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$18.20
▼ -4.21%
Market Cap
$589,061
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
1.73
52-Wk Range
2.2973-209.23424
CEO
Katharyn Field
Country
GB
Currency
USD
Akanda Corp., operating through its various subsidiary entities, focuses on the cultivation, production, and distribution of cannabis products. The company's operations span the United Kingdom, Lesotho, and other global regions, with a specific aim to provide cannabis-derived items for medical and wellness purposes. Formed in 2021, Akanda Corp. is based out of its main office in New Romney, United Kingdom.
Open full interactive analysis & DCF →